Pharmacy News

New study gives insight into statins and muscle pain

While many patients who stop taking statins say that adverse effects, including muscle pain, is to blame, a new study in The Lancet says the drugs are not the cause of the pain for most statin patients reporting it.

ACIP issues recommendations on seasonal influenza vaccines

According to CDC’s 2022–2023 Advisory Committee on Immunization Practices (ACIP) recommendations, all vaccines for the approaching influenza season will be quadrivalent. Trivalent influenza vaccines have been taken out of circulation.

USPSTF updates statin recommendations for CVD prevention in adults

The U.S. Preventive Services Task Force (USPSTF) has issued new recommendations governing the use of statins for primary prevention of cardiovascular disease (CVD) in patients age 40 to 75 years with no history of CVD and no signs or symptoms of it.

Researchers examine metformin, ivermectin, and fluvoxamine for COVID-19

The research community is challenged to identify safe and effective treatments for early COVID-19 disease that patients can take at home. While monoclonal antibodies represent one option, the constant evolution of the coronavirus creates barriers.

Study highlights urgency of removing access to OUD meds

Researchers at NYU Grossman School of Medicine say 86.6% of people living with opioid use disorder (OUD) in the United States are not receiving medications proven to reduce opioid overdoses, including methadone, buprenorphine, and extended-release naltrexone. Their study, published in International Journal of Drug Policy, looked at differences between new estimates of OUD prevalence and the use of medications for OUD (MOUD) at the national and state levels from 2010 to 2019.